Global Biologic Therapeutics Market 2018-2022

Global Biologic Therapeutics Market 2018-2022

About this market

Increasing incidence of chronic diseases and immunological disorders to drive growth in the market. Biologics are ideal for the treatment of chronic disorders including cancer, autoimmune disorders, hormonal deficiencies, neurological disorders, and other critical conditions. The incidence of these diseases is rising significantly in developed nations. The increase in aging population and the lifestyle of people in these countries is responsible for the rise in occurrence of cancer, immunological disorders, and other chronic ailments. Technavio’ s analysts have predicted that the biologic therapeutics market will register a CAGR of over11% by 2022.

Market Overview

Increasing investment in development of biologics

Biotechnological products help manufacturers to earn huge revenues because of the therapeutic benefits they provide. Thus, many pharmaceutical companies are moving toward the development of biologics.

Reimbursement challenges of new biologics

The reimbursements available for biologics are very limited compared with that available for conventional therapeutics, despite the high costs. Manufacturers are providing biologics with mandatory companion diagnostics, which increases the overall cost of that biologic, making it difficult for insurers to provide reimbursements.

For the detailed list of factors that will drive and challenge the growth of the biologic therapeutics market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Merck and Pfizer the competitive environment is quite intense. Factors such as the increasing incidence of chronic diseases and immunological disorders and the increasing investment in development of biologics, will provide considerable growth opportunities to biologic therapeutics manufactures. AbbVie, Johnson & Johnson, Merck, and Pfizer are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Biologic Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global biologic therapeutics market: AbbVie, Johnson & Johnson, Merck, and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the increasing incidence of chronic diseases and immunological disorders.”

According to the report, one of the major drivers for this market is the increasing investment in development of biologics.

Further, the report states that one of the major factors hindering the growth of this market is the reimbursement challenges of new biologics.

Companies Mentioned

AbbVie
Johnson & Johnson
Merck
Pfizer

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global biologic therapeutics market: Segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Biologics in pipeline 2017-2018
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ bn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by type of therapeutic agent
    • Segmentation by therapeutic agent
      • Table Global biologic therapeutics market - Market share by therapeutic agent 2017-2022 (%)
    • Comparison by therapeutic agent
      • Table Comparison by therapeutic agent
    • Monoclonal antibodies - Market size and forecast 2017-2022
      • Table Monoclonal antibodies - Market size and forecast 2017-2022 ($ bn)
      • Table Sales of major monoclonal antibodies 2015-2017
      • Table Monoclonal antibodies - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ bn)
      • Table Others - Year-over-year growth 2018-2022 (%)
    • Vaccines - Market size and forecast 2017-2022
      • Table Vaccines - Market size and forecast 2017-2022 ($ bn)
      • Table Vaccines - Year-over-year growth 2018-2022 (%)
    • Cell and tissue-based therapy - Market size and forecast 2017-2022
      • Table Cell and tissue-based therapy - Market size and forecast 2017-2022 ($ bn)
      • Table Cell and tissue-based therapy - Year-over-year growth 2018-2022 (%)
    • Gene therapy - Market size and forecast 2017- 2022
      • Table Gene therapy- Market size and forecast 2017-2022 ($ bn)
      • Table Gene therapy- Year-over-year growth 2018-2022 (%)
    • Market opportunity by therapeutic agent
      • Table Market opportunity by type of therapeutic agent
  • Market segmentation by application
    • Oncology
      • Table Sales of biologics used in oncology 2015-2017 ($ millions)
    • Autoimmune and inflammatory diseases
    • Hematology
    • Others
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global biologic therapeutics market - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top three countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top three countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ bn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top three countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Treatment costs of some recently approved biologics in US
  • Market trends
    • Table Patent expiration dates of some biologics
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors Covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie overview
      • Table AbbVie - Business segments
      • Table AbbVie - Organizational developments
      • Table AbbVie - Geographic focus
      • Table AbbVie - Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
    • Merck
      • Table Merck overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
    • Pfizer
      • Table Pfizer overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook